Clinical Trial: A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Pneumococcal Infection
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Children and Adolescents With Increased Risk of Pneumococcal Disease
Brief Summary:
The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of V116 compared to PPSV23 in children 2 through 17 years of age.Researchers want to learn if V116 is as good as, or is better than the PPSV23 vaccine in terms of the antibody immune response.V116 and PPSV23 will be studied in children and teenagers who have a higher risk of getting invasive pneumococcal disease (IPD).
Read more